(Q44425348)

2 December 2017

Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain (English)

1 reference

2 December 2017

0 references

0 references

1 reference

3

Christer Halldin

1 reference

2 December 2017

4

Lars Farde

1 reference

2 December 2017

Magdalena Nord

1

1 reference

PubMed ID

23351590

2 December 2017

Sjoerd J Finnema

series ordinal

2

1 reference

2 December 2017

25 January 2013

1 reference

The International Journal of Neuropsychopharmacology

2 December 2017

1 reference

2 December 2017

16

1 reference

2 December 2017

7

1 reference

2 December 2017

1577-1586

1 reference

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

2 December 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Quantitative analysis of [11C]AZ10419369 binding to 5-HT1B receptors in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

A rapid and reliable method for the quantitation of tricyclic antidepressants in serum using HPLC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Serotonin1B receptors: from protein to physiological function and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Therapeutic drug monitoring of escitalopram in an outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Measuring endogenous 5-HT release by emission tomography: promises and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

[N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001617

7 January 2021

10.1017/S1461145712001617

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

23351590